Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Decoding the dark proteome through interdisciplinary training and research

Obiettivo

In the era of precision medicine, we face a startling paradox: while sequencing entire genomes is routine, we remain blind to thousands of small open reading frames (smORFs) encoding microproteins that constitute a vast dark proteome. Recent breakthroughs have revealed their critical roles in diverse biological processes. This previously overlooked layer represents a fundamental gap in our understanding of cellular function and a major untapped source of therapeutic opportunities. Despite growing recognition by initiatives like Cancer Research UK Grand Challenges, the field remains critically immature with fragmented research, non-standardized methodologies, and most critically, an acute shortage of scientists with multidisciplinary expertise. This human capital bottleneck prevents Europe from establishing leadership.

ORFeus addresses this by training 15 interdisciplinary scientists bridging computational biology, proteogenomics, and therapeutic development. Our consortium unites 15 leading European academics with 14 strategic industry partners spanning technology pioneers, AI innovators, and pharmaceutical developers. Through mandatory integrated training, industry secondments, and cutting-edge technologies, every researcher becomes both computationally and experimentally proficient, a crucial 'bilingual' skillset currently unavailable through traditional programs.

The program delivers groundbreaking innovations: AI-powered prediction tools, standardized workflows through the open-access ORFeome platform, and novel cancer immunotherapy targets. By creating Europe's first comprehensive dark proteome training program, ORFeus transforms this fragmented field into a mature research domain. Our graduates will drive innovation across academia and biotechnology, translate discoveries into clinical applications, and secure Europe's leadership in illuminating this vast unexplored dimension of human biology with profound implications for precision medicine.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2025-DN-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
Contributo netto dell'UE
€ 305 285,76
Costo totale
Nessun dato

Partecipanti (13)

Partner (19)